FdaApplication

ANDA 210188

Back to search

Identifiers

Properties

PropertyValue
applicant_nameCADILA HEALTHCARE LTD
application_typeANDA
approval_date2019-08-19

Products (2)

ProductActive ingredientStrengthDosage form
RANOLAZINERANOLAZINE500MGTABLET, EXTENDED RELEASE;ORAL
RANOLAZINERANOLAZINE1GMTABLET, EXTENDED RELEASE;ORAL

2 products